Black Friday Sale - Ends Soon!
-35% Off Everything
VRTX

Vertex Pharmaceuticals Incorporated (VRTX)

Last Price$468.10.8%
Market Cap$124.0B
LTM Revenue
$10.6B
YoY Growth
+9.9%
3Y CAGR
+14.2%
5Y CAGR
+24.0%
Stock quality & Intrinsic value
7/10
30.9% overvalued

Vertex Pharmaceuticals Incorporated Revenue

Annual
Quarterly
LTM
Crunching data... Almost there!
Dec'04Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
Revenue
$102.7M
$160.9M
$216.4M
$199.0M
$175.5M
$102.0M
$143.4M
$1,410.6M
$1,527.0M
$1,212.0M
$580.4M
$1,032.3M
$1,702.2M
$2,488.7M
$3,047.6M
$4,162.8M
$6,205.7M
$7,574.4M
$8,930.7M
$9,869.2M
VRTX
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for VRTX and see if it's the right time to invest.
Dive in

Vertex Pharmaceuticals Incorporated (VRTX) Revenue comparison analysis

Crunching data... Almost there!

Discover more Stock Ideas

Loved by
investors
worldwide
10K+
Investors use our platform
#1
Top value investing hub with all necessary tools
1K+
Experienced investors in our community
4.9
Average rating across all rating platforms

FAQ

1) What is Vertex Pharmaceuticals Incorporated's Revenue?

As of today, Vertex Pharmaceuticals Incorporated's last 12-month Revenue is $10.6B, based on the financial report for Sep 30, 2024 (Q3 2024).

2) What is Vertex Pharmaceuticals Incorporated's Revenue growth rate?

Over the last year, Vertex Pharmaceuticals Incorporated's Revenue growth was 9.9%. The average annual Revenue growth rates for Vertex Pharmaceuticals Incorporated have been 18.3% over the past three years, 24.0% over the past five years.

3) Is Vertex Pharmaceuticals Incorporated's Revenue growth rate Good?

Over the last year, Vertex Pharmaceuticals Incorporated's Revenue growth was 9.9%, which is higher than industry growth of 3.0%. It indicates that Vertex Pharmaceuticals Incorporated's Revenue growth is Good.

4) How does Vertex Pharmaceuticals Incorporated's Revenue growth rate compare to its peers?

Over the last year, Vertex Pharmaceuticals Incorporated's Revenue growth was 9.9%, which is lower than peer median growth of 13.8%. The list of peers includes NVO, REGN, MRNA, INCY, BGNE, BNTX, UTHR, ARGX, ALNY, SMMT etc.